Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity of 9-valent HPV Vaccine in Immunocompromised Children and Adolescents

NCT05439083 is registered in ClinicalTrials.gov with Talia Sainz Costa as lead sponsor.

NCT NCT05439083
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05439083 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity of 9-valent HPV Vaccine in Immunocompromised Children and Adolescents
Lead sponsor
Talia Sainz Costa
Phase
Phase 4
Overall status
Unknown status
Start date
March 7, 2023
Completion date
March 1, 2025
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

human papilloma virus infection